NCT00996242View on ClinicalTrials.gov

An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

March 31, 2009

Conditions
Schizophrenia
Interventions
DRUG

L-lysine

6 g/day for four weeks

Trial Locations (1)

SE 405 30

Sahlgrenska Univeristy Hospital, Gothenburg

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Göteborg University

OTHER

NCT00996242 - An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter